POC HIV Testing and Early DTG Use for Infants
Point-of-Care HIV Testing and Early Dolutegravir Use for Infants
Sponsor: Botswana Harvard AIDS Institute Partnership
This PHASE4 trial investigates HIV and is currently ongoing. Botswana Harvard AIDS Institute Partnership leads this study, which shows 9 recorded versions since 2022 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
9 versions recorded-
Feb 2026 — Present [monthly]
Active Not Recruiting PHASE4
-
Jan 2025 — Feb 2026 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
-
Sep 2024 — Jan 2025 [monthly]
Recruiting PHASE4
-
Aug 2024 — Sep 2024 [monthly]
Recruiting PHASE4
-
Jul 2024 — Aug 2024 [monthly]
Recruiting PHASE4
▶ Show 4 earlier versions
-
Aug 2023 — Jul 2024 [monthly]
Recruiting PHASE4
-
Sep 2022 — Aug 2023 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Jul 2022 — Sep 2022 [monthly]
Not Yet Recruiting PHASE4
-
Jun 2022 — Jul 2022 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Botswana Harvard AIDS Institute Partnership
- Botswana Ministry of Health
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Harvard School of Public Health (HSPH)
- Ragon Institute of MGH, MIT and Harvard
For direct contact, visit the study record on ClinicalTrials.gov .